TrialJournal of gastroenterology2018

Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapy.

Akihiro Matsumoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.